Dihydroceramide Desaturase-1 (Des1) Inhibitors for the Treatment of Fibrotic Disease

  • Flynn, Bernard (Primary Chief Investigator (PCI))
  • Kelly, Darren (Chief Investigator (CI))
  • Wang, Bing (Chief Investigator (CI))
  • Reid, Christopher (Chief Investigator (CI))
  • Pitson, Stuart (Chief Investigator (CI))

Project: Research

StatusActive
Effective start/end date1/01/1931/12/20

Funding

  • National Health & Medical Research Council (NHMRC): AUD680,824.60